Biosimilar Newsletter Archive

  1. 12.08.22 -- Biocon Completes Acquisition Of Viatris Biosimilar Business 12/8/2022
    12/08/22 Biosimilar Development Newsletter
  2. 12.07.22 -- Top 2022 Articles On Process Development 12/7/2022

    12/07/22 Biosimilar Development Newsletter

  3. 12.01.22 -- Key Insights From 2022 FDA/PDA Joint Conference 12/1/2022
    12/01/22 Biosimilar Development Newsletter
  4. 11.23.22 -- CDMO Selection In Our Post-COVID World 11/23/2022
    11/23/22 Biosimilar Development Newsletter
  5. 11.17.22 -- Improve And Intensify Your Upstream Processes 11/17/2022

    11/17/22 Biosimilar Development Newsletter

  6. 11.17.22 -- A Phased Approach To Adopt In-Line Monitoring & Real-Time Release 11/17/2022
    11/17/22 Biosimilar Development Newsletter
  7. 11.10.22 -- Pharma 4.0 Software Methodologies In Biopharma & Medical Devices 11/10/2022
    11/10/22 Biosimilar Development Newsletter
  8. 11.07.22 -- Take Control Of Your Biomanufacturing Capacity And Timelines 11/7/2022
    11/07/22 Biosimilar Development Newsletter
  9. 11.03.22 -- Tips For Your Virtual Meetings With The FDA 11/3/2022
    11/03/22 Biosimilar Development Newsletter
  10. 11.02.22 -- How To De-Risk Your Biologic's Development And Manufacturing Process 11/2/2022

    11/02/22 Biosimilar Development Newsletter